Literature DB >> 19882341

Heart rate variability in familial Mediterranean fever.

Naomi Nussinovitch1, Avi Livneh, Keren Katz, Pnina Langevitz, Olga Feld, Moshe Nussinovitch, Benjamin Volovitz, Merav Lidar, Udi Nussinovitch.   

Abstract

Familial Mediterranean fever (FMF) is a hereditary disease, characterized by recurrent episodes of fever and polyserositis. Heart rate variability (HRV) is a powerful, simple and reliable technique to evaluate autonomic nervous system function. Previous studies of physiologic parameters during tilt-test have suggested that patients with FMF have abnormal cardiovascular reactivity and occult dysautonomia. Prompted by these findings, the present study sought to evaluate HRV in patients with FMF, at rest and in the standing position. The study sample included 34 patients with FMF and 34 sex- and age-matched control subjects. All underwent electrocardiography according to strict criteria. HRV parameters were computed with custom-made software. There was no significant difference in HRV parameters, in either the supine or standing position, between the FMF and control groups. In both groups, the upright position was associated with a significant decrease, when compared with the supine position, in maximal RR interval, minimal RR, average RR, root square of successive differences in RR interval, number of intervals differing by >50 ms from preceding interval (NN50), NN50 divided by total number of intervals (pNN50) and high-frequency components as well as a significant increase in average heart rate, very low frequency or low-frequency components, low-frequency/high-frequency components ratio and total power. In conclusion, patients with FMF who are continuously treated with low-dose colchicine have not developed amyloidosis and have normal HRV parameters in the supine and upright position. Further investigation of occult dysautonomia in FMF is needed.

Entities:  

Mesh:

Year:  2009        PMID: 19882341     DOI: 10.1007/s00296-009-1214-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

2.  The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever.

Authors:  Ruth Gershoni-Baruch; Riva Brik; Nurit Zacks; Maruan Shinawi; Merav Lidar; Avi Livneh
Journal:  Arthritis Rheum       Date:  2003-04

3.  Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures.

Authors:  S Maule; R Quadri; D Mirante; R A Pellerito; E Marucco; C Marinone; D Vergani; L Chiandussi; M M Zanone
Journal:  Clin Exp Immunol       Date:  1997-12       Impact factor: 4.330

4.  Cardiovascular autonomic dysfunction in familial Mediterranean fever.

Authors:  Michael Rozenbaum; Jochanan E Naschitz; Marina Yudashkin; Itzhak Rosner; Edmond Sabo; Naomi Shaviv; Luis Gaitini; Eli Zuckerman; Daniel Yeshurun
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

5.  Criteria for the diagnosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; D Zemer; N Zaks; S Kees; T Lidar; A Migdal; S Padeh; M Pras
Journal:  Arthritis Rheum       Date:  1997-10

6.  Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF.

Authors:  Ali Akdogan; Meral Calguneri; Bunyamin Yavuz; E Bengi Arslan; Umut Kalyoncu; Levent Sahiner; Omer Karadag; Ihsan Ertenli; Sedat Kiraz; Kudret Aytemir; Deniz Akata; Lale Tokgozoglu; Ali Oto
Journal:  J Am Coll Cardiol       Date:  2006-11-09       Impact factor: 24.094

Review 7.  Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation.

Authors:  J D England; G S Gronseth; G Franklin; G T Carter; L J Kinsella; J A Cohen; A K Asbury; K Szigeti; J R Lupski; N Latov; R A Lewis; P A Low; M A Fisher; D N Herrmann; J F Howard; G Lauria; R G Miller; M Polydefkis; A J Sumner
Journal:  Neurology       Date:  2008-12-03       Impact factor: 9.910

8.  Colchicine stimulates the rate of contraction of heart cells in culture.

Authors:  I Klein
Journal:  Cardiovasc Res       Date:  1983-08       Impact factor: 10.787

9.  The detailed assessment of left and right ventricular functions by tissue Doppler imaging in patients with familial Mediterranean fever.

Authors:  Yusuf Tavil; Kemal Ureten; Mehmet Akif Oztürk; Nihat Sen; Mehmet Güngör Kaya; Mustafa Cemri; Atiye Cengel
Journal:  Clin Rheumatol       Date:  2007-07-24       Impact factor: 2.980

10.  Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever.

Authors:  Ismail Sari; Oguzhan Karaoglu; Gercek Can; Servet Akar; Aytac Gulcu; Merih Birlik; Nurullah Akkoc; Mehmet Tunca; Yigit Goktay; Fatos Onen
Journal:  Clin Rheumatol       Date:  2007-01-23       Impact factor: 3.650

View more
  11 in total

1.  Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF).

Authors:  Udi Nussinovitch; Avi Livneh; Benjamin Volovitz; Moshe Nussinovitch; Ilan Ben-Zvi; Merav Lidar; Naomi Nussinovitch
Journal:  Clin Rheumatol       Date:  2012-04-18       Impact factor: 2.980

2.  QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients.

Authors:  Udi Nussinovitch; Keren Kaminer; Moshe Nussinovitch; Benjamin Volovitz; Merav Lidar; Naomi Nussinovitch; Avi Livneh
Journal:  Clin Rheumatol       Date:  2012-01-25       Impact factor: 2.980

3.  Reliability of Ultra-Short ECG Indices for Heart Rate Variability.

Authors:  Udi Nussinovitch; Keren Politi Elishkevitz; Keren Katz; Moshe Nussinovitch; Shlomo Segev; Benjamin Volovitz; Naomi Nussinovitch
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-04       Impact factor: 1.468

4.  P-wave dispersion in systemic AA amyloidosis of familial Mediterranean fever.

Authors:  Udi Nussinovitch; Avi Livneh; Moshe Nussinovitch; Benjamin Volovitz; Ilan Ben-Zvi; Merav Lidar; Naomi Nussinovitch
Journal:  Clin Rheumatol       Date:  2011-04-12       Impact factor: 2.980

5.  Heart rate variability in familial Mediterranean fever patients.

Authors:  Hakan Kaya; Arif Süner; Sedat Köroğlu; Ahmet Akçay; İbrahim Halil Türkbeyler; Murat Köleoğlu
Journal:  Eur J Rheumatol       Date:  2014-06-01

6.  Cardiac autonomic functions in children with familial Mediterranean fever.

Authors:  Murat Şahin; Mustafa Kır; Balahan Makay; Pembe Keskinoğlu; Elçin Bora; Erbil Ünsal; Nurettin Ünal
Journal:  Clin Rheumatol       Date:  2014-06-15       Impact factor: 2.980

7.  QT dispersion in amyloidosis due to familial Mediterranean fever.

Authors:  Udi Nussinovitch; Naomi Nussinovitch; Moshe Nussinovitch; Benjamin Volovitz; Olga Feld; Ilan Ben-Zvi; Avi Livneh
Journal:  Rheumatol Int       Date:  2011-04-02       Impact factor: 2.631

8.  Normal autonomic nervous system responses in uncomplicated familial Mediterranean fever: a comparative case-control study.

Authors:  Udi Nussinovitch; Avi Livneh; Keren Kaminer; Pnina Langevitz; Olga Feld; Moshe Nussinovitch; Benjamin Volovitz; Merav Lidar; Naomi Nussinovitch
Journal:  Clin Rheumatol       Date:  2011-05-04       Impact factor: 2.980

9.  P wave dispersion in familial Mediterranean fever.

Authors:  Naomi Nussinovitch; Avi Livneh; Keren Katz; Moshe Nussinovitch; Benjamin Volovitz; Merav Lidar; Udi Nussinovitch
Journal:  Rheumatol Int       Date:  2010-05-23       Impact factor: 2.631

Review 10.  Cardiac disease in familial Mediterranean fever.

Authors:  Eren Erken; Ertugrul Erken
Journal:  Rheumatol Int       Date:  2017-10-20       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.